Table 1: Summary of nutrient
anti-inflammatory concentrations.
Nutrient |
Concentration/Dose |
Delivery
method |
Cell/Animal
type |
Ref. |
Amino Acids |
||||
Glutamine |
15-240 mM |
in vitro |
HT29 cells |
[12] |
Arginine |
2.5-50 mM |
in vitro |
HT29 cells |
[12] |
Cysteine |
0.2-20 mM |
in vitro |
THP-1 cells |
[13] |
Histidine |
20 mM |
in vitro |
THP-1 cells |
[13] |
626 mg |
Oral, in vivo |
SCID mice |
[14] |
|
Glycine |
20 mM |
in vitro |
THP-1 cells |
[13] |
50 g/kg |
Oral, in vivo |
Wistar rats |
[15] |
|
Selenium/ Selenocysteine |
0.4-1.0 ppm |
Oral, in vivo |
C57BL/6 mice |
[29] |
Kynurenic
acid |
25 mg/kg |
IV, in vivo |
Sprague-Dawley
rats |
[33] |
γ-glutamyl cysteine and γ-glutamyl
valine |
0.5 mM |
in vitro |
Caco-2 cells |
[35] |
150 mg/kg |
Oral, in vivo |
BALB/c mice |
[35] |
|
FATS |
||||
Eicosapentaenoic
acids |
100 μM |
in vitro |
THP-1 cells |
[41] |
Docosahexaenoic
acids |
100 μM |
in vitro |
THP-1 cells |
|
α-linolenic acid |
100 μM |
in vitro |
THP-1 cells |
[40] |
Conjugated
linoleic acid |
45-80 mg/day |
Oral, in vivo |
C57BL6/J mice |
[51] |
Vitamins |
||||
Vitamin A |
41 IU/kg/day |
Oral, in vivo |
Sprague-Dawley
rats |
[56] |
Vitamin D |
50 IU/day |
Oral, in vivo |
C57BL/6 mice |
[59] |
Vitamin E |
800 mg/day |
Oral, in vivo |
Human |
[65] |
|
500 ppm |
Oral, in vivo |
Mice |
[65] |
Flavonoids |
||||
Citrus
flavonoids (Hesperidin and Diosmin) |
500 mg Daflon |
in vitro |
Endothelial
fibroblasts, RBL-2H3 cells |
|
100 mg/d Daflon |
SC, in vivo |
Rats |
[76] |
|
Apigenin |
10-30 μM |
in vivo |
J773.2 cells, RAW 264.7 cells |
|
|
50 mg/kg |
IV, in vitro |
C57BL/6J mice |
[79] |
Baicalein |
10 μM |
in vitro |
RAW264.7 cells |
[81] |
Genistein |
10-100 μM |
in vitro |
J774 cells |
[83] |
Others |
||||
Curcumin |
12.5-30 μmol/L |
in vitro |
lymphocytes |
[89] |
Resveratrol |
50 μM |
in vitro |
J773.2 cells |
[78] |
S-allyl cysteine |
80 mg/kg |
Oral, in vivo |
Rats |
[101] |